Epigral Targets Rs. 50 bn Revenue by FY31 Through Capacity Expansion
ECONOMY & POLICY

Epigral Targets Rs. 50 bn Revenue by FY31 Through Capacity Expansion

Specialty chemicals manufacturer Epigral is targeting revenue of Rs. 50 bn by FY31, supported by production capacity expansions in chlorinated polyvinyl chloride (CPVC) resin and epichlorohydrin (ECH), Chairman and Managing Director Maulik Patel said. The company expects revenue to reach Rs. 29 bn in the current financial year, compared with Rs. 25-25.3 bn reported for FY26.

Epigral is doubling its CPVC resin capacity from 75,000 t to 150,000 t annually and its ECH capacity from 50,000 t to 100,000 t. Both projects are located at the company’s existing units in Dahej, Gujarat, and are expected to be commissioned within the next few months.

The expansion phase involves capital expenditure of Rs. 6.5 bn, which has been funded entirely through internal accruals. The projects are expected to make a partial contribution to revenue during the current financial year and a more meaningful contribution from the next financial year as the additional capacity is utilised.

Epigral entered the ECH and CPVC resin businesses in 2022 after deciding to focus on import-substitution products. The company produces ECH using a renewable glycerine-based process rather than the crude-oil-based propylene route commonly used in Western markets. It has also established itself as India’s largest CPVC resin producer and aims to become the world’s largest manufacturer in the category after the capacity expansion.

The company has acquired additional land near its Dahej facility for a new chemistry line and is finalising a technology partner. The project is expected to be placed before the board in another quarter and will target a product for which about 90 per cent of Indian demand is currently met through imports. Patel did not disclose the planned capital expenditure but said it would exceed Rs. 10 bn.

Specialty chemicals manufacturer Epigral is targeting revenue of Rs. 50 bn by FY31, supported by production capacity expansions in chlorinated polyvinyl chloride (CPVC) resin and epichlorohydrin (ECH), Chairman and Managing Director Maulik Patel said. The company expects revenue to reach Rs. 29 bn in the current financial year, compared with Rs. 25-25.3 bn reported for FY26. Epigral is doubling its CPVC resin capacity from 75,000 t to 150,000 t annually and its ECH capacity from 50,000 t to 100,000 t. Both projects are located at the company’s existing units in Dahej, Gujarat, and are expected to be commissioned within the next few months. The expansion phase involves capital expenditure of Rs. 6.5 bn, which has been funded entirely through internal accruals. The projects are expected to make a partial contribution to revenue during the current financial year and a more meaningful contribution from the next financial year as the additional capacity is utilised. Epigral entered the ECH and CPVC resin businesses in 2022 after deciding to focus on import-substitution products. The company produces ECH using a renewable glycerine-based process rather than the crude-oil-based propylene route commonly used in Western markets. It has also established itself as India’s largest CPVC resin producer and aims to become the world’s largest manufacturer in the category after the capacity expansion. The company has acquired additional land near its Dahej facility for a new chemistry line and is finalising a technology partner. The project is expected to be placed before the board in another quarter and will target a product for which about 90 per cent of Indian demand is currently met through imports. Patel did not disclose the planned capital expenditure but said it would exceed Rs. 10 bn.

Related Stories

Gold Stories

Next Story
Equipment

TIL Revenue Surges 143% to Rs 1.98 Billion in Q2 FY27

TIL Limited, a manufacturer of material handling and infrastructure equipment, has reported a 143 per cent year-on-year increase in consolidated revenue to Rs 1.98 billion for the second quarter of FY27, compared with Rs 814.5 million in the corresponding period last year. Consolidated EBITDA surged 433 per cent to Rs 173.7 million, while EBITDA margin improved to 8.8 per cent from 4 per cent.The performance was supported by equipment deliveries, defence contracts, aftermarket services and the contribution of Tulip Compression Private Limited (TCPL), which became a majority-owned subsidiary in..

Next Story
Infrastructure Transport

India to Develop Civil Aircraft Within Two Years, Build 100 Airports

India aims to develop its own civil aircraft within the next two years as it seeks to strengthen domestic aerospace capabilities and reduce dependence on foreign aircraft manufacturers, Civil Aviation Minister Ram Mohan Naidu said on November 12. He said the ambition extended beyond assembling aircraft to developing expertise in aircraft design and production. Speaking at the inaugural session of the Confederation of Indian Industry (CII) Partnership Summit 2026 in Visakhapatnam, Naidu said India wanted to establish itself as a major aerospace manufacturing hub. The government’s approach is ..

Next Story
Infrastructure Urban

Two Korean Firms to Invest Rs. 13.7 bn in Tamil Nadu

Two South Korean automotive component suppliers to Hyundai and Kia plan to invest a combined Rs. 13.7 bn in Tamil Nadu over the next five years, according to sources in the state industries department. The proposed investments come after a political dispute over the reported movement of some automotive investments to Andhra Pradesh. The state government has received letters of intent (LoIs) from Hwashin and Seoyon, while memorandums of understanding (MoUs) are expected to be signed shortly. Both companies communicated their investment plans in letters dated November 11, reaffirming their inten..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code